Syndax Drug Patent Portfolio
Syndax owns 1 orange book drug protected by 2 US patents Given below is the list of Syndax's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10683302 | Inhibitors of the menin-MLL interaction | 08 Jun, 2037 | Active |
| US11479557 | Inhibitors of the menin-MLL interaction | 08 Jun, 2037 | Active |
Latest Legal Activities on Syndax's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Syndax.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Initial letter Re: PTE Application to regulating agency | 15 Jan, 2025 | US10683302 |
| Patent Term Extension Application under 35 USC 156 Filed | 13 Jan, 2025 | US10683302 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 06 Dec, 2023 | US10683302 |
| Recordation of Patent Grant Mailed | 25 Oct, 2022 | US11479557 |
| Patent Issue Date Used in PTA Calculation | 25 Oct, 2022 | US11479557 |
| Email Notification | 06 Oct, 2022 | US11479557 |
| Issue Notification Mailed | 05 Oct, 2022 | US11479557 |
| Application Is Considered Ready for Issue | 13 Sep, 2022 | US11479557 |
| Dispatch to FDC | 13 Sep, 2022 | US11479557 |
| Issue Fee Payment Verified | 02 Sep, 2022 | US11479557 |
| Issue Fee Payment Received | 02 Sep, 2022 | US11479557 |
| Electronic Review | 08 Jun, 2022 | US11479557 |
| Email Notification | 08 Jun, 2022 | US11479557 |
| Mail Notice of Allowance | 08 Jun, 2022 | US11479557 |
| Notice of Allowance Data Verification Completed | 04 Jun, 2022 | US11479557 |
Syndax's Family Patents
Syndax Drug List
Given below is the complete list of Syndax's drugs and the patents protecting them.
1. Revuforj
Revuforj is protected by 2 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10683302 | Inhibitors of the menin-MLL interaction |
08 Jun, 2037
(11 years from now)
| Active |
| US11479557 | Inhibitors of the menin-MLL interaction |
08 Jun, 2037
(11 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Revuforj's drug page